The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes (the CHEC-SC study)
C
Clement Ren, MD
Primary Investigator
Recruiting
1-100 years
All
Phase
N/A
1 Location
Brief description of study
This study will collect contemporary sweat chloride values from cystic fibrosis patients prescribed and currently receiving commercially approved CFTR modulator therapies.
Detailed description of study
This is a multicenter, cross-sectional, cohort study which will collect contemporary SC values from approximately 1000 CF patients prescribed and currently receiving commercially approved CFTR modulator therapies.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: cystic fibrosis, Riley
-
Age: Between 1 Years - 100 Years
-
Gender: All
Inclusion Criteria
Documentation of a CF diagnosis
Current treatment with a prescribed commercially approved CFTR modulator for at least 3 months prior to enrollment
Exclusion Criteria
Presence of a condition or abnormality that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data
Currently enrolled in an investigational trial (including open-label follow-on studies and EAPs) of an agent expected to have an impact on sweat chloride
Additional Information:Documentation of a CF diagnosis
Current treatment with a prescribed commercially approved CFTR modulator for at least 3 months prior to enrollment
Exclusion Criteria
Presence of a condition or abnormality that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data
Currently enrolled in an investigational trial (including open-label follow-on studies and EAPs) of an agent expected to have an impact on sweat chloride
Participants will not be paid for their participation.
Updated on
13 Sep 2024.
Study ID: 1712442067
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
